To slow Researchers discover possible therapeutic target in Parkinson’s diseaseUniversity of Medicine and Dentistry of New Jersey researchers have a therapeutic aim, if manipulated, can the progression of slow or stop Parkinson’s disease, a debilitating neurodegenerative disorder, affects discovered an estimated one million people in the U.S.
A team from the center for Neurodegenerative and neuroimmunological diseases in the department of neurology at UMDNJ – Robert Wood Johnson Medical School who led the study. Maral Mouradian, director of the center , and William Dow Lovett Professor of Neurology, was its principal investigator. Paper paper on their findings under the title The suppression of a-synuclein expression and toxicity by microRNA-7 will appear in the 20th July issue of Proceedings of the National Academy of Sciences .Asked to healthcare IT case receive high priority, according to Opinion piece.
with kind permission of you can entire Kaiser Daily Health Policy indicate Report search in the archives and sign up for email with an on Kaiser Daily HealthPolicyMonitor Report strongly committed kaiser network. A free service of The Henry J. Publishes. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.